SCHEMBL6219453

SCHEMBL6219453

CN(C)CCCn1c2ccccc2c2ccccc21.ClCCCn1c2ccccc2c2ccccc21

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.65
DRD3 P35462 2/20 0.55
CHRM2 P08172 1/20 0.55
HTR1A P08908 1/20 0.55
CHRM5 P08912 1/20 0.55
ADRA2A P08913 1/20 0.55
DRD2 P14416 1/20 0.55
ADRA2B P18089 1/20 0.55
ADRA2C P18825 1/20 0.55
CHRM3 P20309 1/20 0.55
DRD4 P21917 1/20 0.55
SLC6A2 P23975 1/20 0.55
HRH2 P25021 1/20 0.55
HTR2A P28223 1/20 0.55
HTR2C P28335 1/20 0.55
AVPR2 P30518 1/20 0.55
ADRA1A P35348 1/20 0.55
HRH1 P35367 1/20 0.55
OPRK1 P41145 1/20 0.55
HTR2B P41595 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL541688 0.92 CYP2D6 (0.74) CYP2D6DRD3CHRM2HTR1ACHRM5
SCHEMBL29907915 0.92 CYP2D6 (0.74) CYP2D6DRD3CHRM2HTR1ACHRM5
SCHEMBL2700703 0.86 FABP4 (0.56) DRD3CNR2FABP4FABP5
SCHEMBL541993 0.86 FABP4 (0.56) DRD3CNR2FABP4FABP5
SCHEMBL10702688 0.82 SLC6A4 (0.64) CYP2D6DRD3CHRM2HTR1ACHRM5
SCHEMBL11834370 0.82 CYP2D6 (0.59) CYP2D6DRD3CHRM2HTR1ACHRM5
SCHEMBL11826363 0.81 CYP2D6 (0.59) CYP2D6DRD3CHRM2HTR1ACHRM5
SCHEMBL4729188 0.81 FABP4 (0.58) FABP4FABP5
Fantridone SCHEMBL1683047 0.79 PGR (0.69) CYP2D6DRD3CHRM2HTR1ACHRM5
SCHEMBL11754129 0.79 KDM4E (0.61) CYP2D6DRD3CHRM2HTR1ACHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1509518-A1 CALCIUM RECEPTOR MODULATING AGENTS Amgen, Inc. (US) 2005-03-02 EP disclosed
WO-2003099814-A1 CALCIUM RECEPTOR MODULATING AGENTS AMGEN, INC. (US) 2003-12-04 WO disclosed